Number of Resected Lymph Nodes and Survival Status in Node-Negative Esophageal Squamous Cell Carcinoma: A Cohort Study
Yifei Lu,Minhua Ye,Dehua Ma,Yu Chen
DOI: https://doi.org/10.2147/ijgm.s480893
IF: 2.145
2024-10-15
International Journal of General Medicine
Abstract:Yifei Lu, 1, &ast Minhua Ye, 2, &ast Dehua Ma, 2 Yu Chen 2 1 Department of Cardiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, People's Republic of China; 2 Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yu Chen; Dehua Ma, Email ; Objective: To explore the association between survival status and the number of resected lymph nodes in node-negative esophageal squamous cell carcinoma(ESCC) after surgical treatment. Methods: This was a retrospective observational cohort study and data were obtained from the Surveillance, Epidemiology, and End Results program (SEER) and TaiZhou hospital in China. The data for subjects with negative lymph nodes and no distant metastasis (pN0M0) after post-operative pathology were screened. The nonlinear relationship between resected lymph node number and survival status in node-negative ESCC was conducted using restricted cubic spline regression analysis. The association between the number of resected lymph nodes and survival status in node-negative ESCC was evaluated by Cox proportional hazards regression models. Subgroup analysis based on different subgroups was also performed. Results: A total of 999 subjects were included in the study. Restricted cubic spline regression was used to show a U shaped association between the number of resected lymph nodes and survival status in node-negative ESCC, with low count associated with a decreased survival. To elucidate the association, we adjusted for age, sex, race, T stage, TNM (tumor node metastasis classification), location, grade, chemotherapy, and radiotherapy. As the resected lymph node number increased by one node, the survival status was improved by 2% (Hazard ratio(HR) = 0.98, 95% confidence interval (CI) 0.98– 0.99). Sensitivity analysis indicate that the effect size and direction in different subgroups are consistent, the results is stability in SEER. Conclusion: A low count of resected lymph nodes correlated with reduced survival in patients with ESCC, where resecting 25 to 28 or more nodes is considered optimal. Larger prospective studies are warranted to confirm these findings. Keywords: number of lymph node resection, survival status, cohort study, nonlinear relationship, node-negative esophageal squamous cell carcinoma Esophageal cancer (EC) ranks as the sixth most prevalent cancer globally, with approximately 604,000 new cases and 544,000 deaths annually. 1 Despite significant advancements in treatment modalities such as surgery, radiotherapy, chemotherapy, immunotherapy, and targeted therapy, the prognosis for EC remains poor. The primary curative treatment for resectable esophageal squamous cell carcinoma (ESCC) is esophagectomy, which ideally includes a thorough lymph node resection (LNR) to achieve an R0 resection. 2,3 The status of lymph nodes is a critical determinant of prognosis and survival in EC patients. Effective LNR allows for the identification of metastatic lymph nodes, guiding adjuvant therapy decisions. However, there is no consensus on the standardized protocol for LNR, particularly regarding the optimal number of lymph nodes that should be excised to ensure an R0 resection in ESCC. 4–6 Current guidelines vary, leaving a gap in the standardization of surgical practices. Given the heterogeneity in lymph node dissection practices and the lack of a clear standard, this study aims to explore the relationship between the number of lymph nodes resected and survival outcomes in node-negative ESCC following esophagectomy. Establishing a minimum number of lymph nodes required for an effective LNR could standardize surgical procedures and potentially improve patient outcomes. Data were obtained from the SEER and TaiZhou hospital database. The SEER 18 registries cover approximately 30% of the US population.( https://seer.cancer.gov ). Data were extracted from the SEER database for 932 ESCC patients who underwent surgical resection between 2004 and 2020 and whose post-operative pathology suggested no lymphatic metastases. Then, data of 67 ESCC patients with lymph node-negative postoperative pathology were extracted from TaiZhou hospital in China from 2014 to 2020 to further analyze the minimum number of lymph nodes that should be removed during surgery for patients with lymph node-negative ESCC. For Dataset TaiZhou hospital, the last follow-up date was may 6, 2022. The inclusion criteria were as follows: 1. Underwent an esophagectomy; 2. ESCC confirmed by postoperative pathological -Abstract Truncated-
medicine, general & internal